脑卒中神经保护剂的治疗现状和未来  

Current situation and the future of neuroprotective drugs for stroke

作　　者：王伊龙[1] 赵性泉[1] 王拥军[1] 陈盼[1] 张倩[1] 

机构地区：[1]首都医科大学附属北京天坛医院神经内科,北京100050

出　　处：《中国新药杂志》2011年第11期985-987,共3页Chinese Journal of New Drugs

摘　　要：神经保护剂通过阻断缺血级联反应阻止神经细胞死亡,已成为近30年人类探索缺血性卒中早期治疗的一个重要途径,并在大量临床前研究中得以证实,然而其临床试验结局却是令人失望的。本文旨在总结脑卒中神经保护剂的治疗现状,分析其未能成功用于临床的可能原因,并探讨未来研究对策。Neuroprotective drugs, which prevent death of neurons by i been an important way for early treatments of ischemic stroke in the last thirty years ing the ischemic Despite many p ies showed satisfactory results, no neuroprotective drug has demonstrated unequivocal efficacy in This article is aimed for clinical failures, cascade, have reclinical studclinical trials. to summarize the current situation of neuroprotective drugs for stroke, analyze possible causes and explore strategies for future studies

关 键 词：神经保护剂 脑卒中 现状 对策 

分 类 号：R971[医药卫生—药品] R969.4[医药卫生—药学]